VEGFR2/CD309 Antikörper (pTyr996)
Kurzübersicht für VEGFR2/CD309 Antikörper (pTyr996) (ABIN218846)
Target
Alle VEGFR2/CD309 (VEGFR2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- pTyr996
-
Spezifität
- Detects overexpressed human VEGFR-2 only when phosphorylated at tyrosine 996. Cross-reacts with tyrosine-phosphorylated PDGF receptor, but does not cross-react with other tyrosine-phosphorylated proteins. Species cross-reactivity: Human and mouse.
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic phosphopeptide corresponding to residues surrounding Tyr996 of human VEGF receptor 2 (KLH coupled).
Type of Immunogen: Synthetic phospho-peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: WB (1:1000)
Usage: Suitable for use in Western Blot. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 10 mM HEPES, pH 7.5, 150 mM sodium chloride, 0.1 mg/mL BSA, 50 % glycerol. No preservative added.
-
Konservierungsmittel
- Without preservative
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Andere Bezeichnung
- KDR / VEGFR2
-
Hintergrund
-
Name/Gene ID: KDR
Subfamily: VEGF Receptor
Family: Protein Kinase
Synonyms: KDR, CD309, Fetal liver kinase 1, Fetal liver kinase-1, FLK-1, FLK1, Kinase insert domain receptor, Quek1, VEGFR, VEGFR2, Soluble VEGFR2, VEGF receptor 2, VEGFR-2, CD309 antigen, VEGF-R2 -
Gen-ID
- 3791
-
UniProt
- P35968
-
Pathways
- RTK Signalweg, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Target
-